HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 295/4/G776    most recent ajpgi.90275.2008v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Labonté, E. D. Articles by Howles, P. N. Search for Related Content PubMed PubMed Citation Articles by Labonté, E. D. Articles by Howles, P. N.

MUCOSAL BIOLOGY

Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1^–/– mice

¹Department of Pathology, Genome Research Institute, University of Cincinnati, Cincinnati, Ohio, and the ²Department of Human Genetics, The Mount Sinai School of Medicine, New York, New York

Submitted 2 April 2008 ; accepted in final form 13 August 2008

The impact of NPC1L1 and ezetimibe on cholesterol absorption are well documented. However, their potential consequences relative to absorption and metabolism of other nutrients have been only minimally investigated. Thus studies were undertaken to investigate the possible effects of this protein and drug on fat absorption, weight gain, and glucose metabolism by using Npc1l1^–/– and ezetimibe-treated mice fed control and high-fat, high-sucrose diets. Results show that lack of NPC1L1 or treatment with ezetimibe reduces weight gain when animals are fed a diabetogenic diet. This resistance to diet-induced obesity results, at least in part, from significantly reduced absorption of dietary saturated fatty acids, particularly stearate and palmitate, since food intake did not differ between groups. Expression analysis showed less fatty acid transport protein 4 (FATP4) in intestinal scrapings of Npc1l1^–/– and ezetimibe-treated mice, suggesting an important role for FATP4 in intestinal absorption of long-chain fatty acids. Concomitant with resistance to weight gain, lack of NPC1L1 or treatment with ezetimibe also conferred protection against diet-induced hyperglycemia and insulin resistance. These unexpected beneficial results may be clinically important, given the focus on NPC1L1 as a target for the treatment of hypercholesterolemia.

diabetogenic diet; glucose metabolism; insulin sensitivity; Western diet; sucrose polybehenate

This article has been cited by other articles:

				C. L. J. Vrins, A. E. van der Velde, K. van den Oever, J. H. M. Levels, S. Huet, R. P. J. Oude Elferink, F. Kuipers, and A. K. Groen Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux J. Lipid Res., October 1, 2009; 50(10): 2046 - 2054. [Abstract] [Full Text] [PDF]